Triple
T4132114
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | rVSV-ZEBOV |
E85063
|
entity |
| Predicate | licensedTo |
P15136
|
FINISHED |
| Object |
NewLink Genetics
NewLink Genetics is a biopharmaceutical company known for developing immuno-oncology therapies and infectious disease vaccines, including holding rights to the rVSV-ZEBOV Ebola vaccine candidate.
|
E414780
|
NE FINISHED |
Provenance (5 batches)
| Stage | Batch ID | Job type | Status |
|---|---|---|---|
| creating | batch_69aed935ccd881909dc61f81bcdb7a78 |
elicitation | completed |
| NER | batch_69af022f55fc81909f2a1a04d0ea59e6 |
ner | completed |
| NED1 | batch_69b576c26d4c81909b8be74855cbd03f |
ned_source_triple | completed |
| NED2 | batch_69b5782cc448819080e306952da24ac0 |
ned_description | completed |
| NEDg | batch_69b577c2b784819096d8218dd1c1478d |
nedg | completed |
Created at: March 9, 2026, 3:42 p.m.